Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China Read more
NeurOp Receives FDA Orphan Drug Designation for NP10679 for Treatment of Subarachnoid Hemorrhage Read more
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases Read more
Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement Read more
CP-COV03, a niclosamide-based oral antiviral drug, under study as possible cure for COVID-19 variants Read more
Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company Read more